Home/Filings/4/0000899243-19-022576
4//SEC Filing

Wilton Thomas 4

Accession 0000899243-19-022576

CIK 0001664106other

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 4:15 PM ET

Size

6.9 KB

Accession

0000899243-19-022576

Insider Transaction Report

Form 4
Period: 2019-08-27
Wilton Thomas
Chief Business Officer
Transactions
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2019-08-27+75,000139,108 total
    Exercise: $0.73Exp: 2027-11-02Common Stock (75,000 underlying)
  • Exercise/Conversion

    Common Stock

    2019-08-27$0.73/sh+75,000$54,75075,000 total
Footnotes (1)
  • [F1]The option vested 25% on the first anniversary of the vesting commencement date, September 6, 2017, and in equal one thirty-sixth monthly installments thereafter.

Issuer

LogicBio Therapeutics, Inc.

CIK 0001664106

Entity typeother

Related Parties

1
  • filerCIK 0001752555

Filing Metadata

Form type
4
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 4:15 PM ET
Size
6.9 KB